IRIS
NARDONE, OLGA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.602
NA - Nord America 2.466
EU - Europa 1.843
SA - Sud America 376
Continente sconosciuto - Info sul continente non disponibili 159
AF - Africa 90
OC - Oceania 10
Totale 8.546
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.334
SG - Singapore 1.568
RU - Federazione Russa 852
CN - Cina 790
VN - Vietnam 563
IT - Italia 445
BR - Brasile 300
HK - Hong Kong 245
BD - Bangladesh 125
FR - Francia 105
DE - Germania 103
NL - Olanda 90
CA - Canada 72
KR - Corea 68
GB - Regno Unito 61
IN - India 58
JP - Giappone 50
FI - Finlandia 40
AR - Argentina 27
MX - Messico 27
PL - Polonia 26
IE - Irlanda 24
ZA - Sudafrica 24
CI - Costa d'Avorio 19
ID - Indonesia 18
TH - Thailandia 17
CO - Colombia 14
PH - Filippine 14
RO - Romania 13
TR - Turchia 13
BG - Bulgaria 12
UA - Ucraina 12
EC - Ecuador 11
IQ - Iraq 11
UZ - Uzbekistan 11
VE - Venezuela 10
ES - Italia 9
MA - Marocco 9
AT - Austria 8
EG - Egitto 8
PK - Pakistan 8
SE - Svezia 8
JM - Giamaica 7
KE - Kenya 6
KZ - Kazakistan 6
MY - Malesia 6
AL - Albania 5
AU - Australia 5
BO - Bolivia 5
TT - Trinidad e Tobago 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
LT - Lituania 4
NG - Nigeria 4
NI - Nicaragua 4
PE - Perù 4
SA - Arabia Saudita 4
TN - Tunisia 4
CL - Cile 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
JO - Giordania 3
LB - Libano 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
AO - Angola 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BE - Belgio 2
CH - Svizzera 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HN - Honduras 2
OM - Oman 2
PA - Panama 2
PY - Paraguay 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
UG - Uganda 2
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
BJ - Benin 1
BY - Bielorussia 1
EE - Estonia 1
GA - Gabon 1
GP - Guadalupe 1
GR - Grecia 1
IR - Iran 1
KW - Kuwait 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
MM - Myanmar 1
MQ - Martinica 1
Totale 8.376
Salva come PNG Salva come JPEG
Città #
Singapore 785
San Jose 441
Hefei 342
Hong Kong 235
Ashburn 227
Moscow 224
Chandler 164
Beijing 162
Ho Chi Minh City 159
Hanoi 140
Naples 117
The Dalles 107
Santa Clara 102
Los Angeles 78
Lauterbourg 68
Seoul 63
New York 55
Amsterdam 51
Tokyo 43
Council Bluffs 40
Buffalo 34
São Paulo 31
Dallas 30
Redondo Beach 30
Milan 28
Haiphong 27
Munich 27
Millbury 26
Napoli 26
Frankfurt am Main 23
Da Nang 22
Montreal 20
Rome 20
Toronto 20
Chicago 19
Helsinki 19
Boston 18
Seattle 18
Warsaw 18
Des Moines 15
Nanjing 15
Orem 15
Boardman 14
Atlanta 12
Johannesburg 12
Sofia 12
Brooklyn 11
Princeton 11
Kochi 10
Lawrence 10
Mexico City 10
Nuremberg 10
Redwood City 10
Tashkent 10
Can Tho 9
Denver 9
Dublin 9
London 9
Phoenix 9
Rio de Janeiro 9
Wilmington 9
Bangkok 8
Düsseldorf 8
New Delhi 8
Jiaxing 7
Miami 7
Ottawa 7
Rochdale 7
San Francisco 7
Thái Bình 7
Thái Nguyên 7
Turku 7
Vienna 7
Ankara 6
Bogotá 6
Bucharest 6
Catania 6
Elk Grove Village 6
Houston 6
Hải Dương 6
Kronberg 6
Nairobi 6
Quito 6
Turin 6
Belo Horizonte 5
Bexley 5
Bắc Ninh 5
Charlotte 5
Chennai 5
Dhaka 5
Kingston 5
Lappeenranta 5
Manchester 5
Memphis 5
Ninh Bình 5
Shenyang 5
Wroclaw 5
Augusta 4
Bari 4
Boydton 4
Totale 4.529
Salva come PNG Salva come JPEG
Nome #
Cross-sectional evaluation of transmural healing in patients with Crohn's disease on maintenance treatment with biologics 168
Cross-sectional evaluation of transmural healing in patients with Crohn's disease on maintenance treatment with anti-TNF alpha agents 168
Successful outcome of the transitional process of inflammatory bowel disease from pediatric to adult age: A five years experience 166
Bowel damage in Crohn's disease: direct comparison of ultrasonography- and magnetic resonance-based Lemann index. 163
Bowel Damage in Crohn's Disease: Direct Comparison of Ultrasonography-based and Magnetic Resonance-based Lemann Index 161
Multi-detector CT enterography in active inflammatory bowel disease: Image quality and diagnostic efficacy of a low-radiation high contrast protocol 157
Prevalence of Sexual Dysfunction in Inflammatory Bowel Disease: Systematic Review and Meta-analysis 155
Adherence in ulcerative colitis: an overview 155
Impact of Sarcopenia on Clinical Outcomes in a Cohort of Caucasian Active Crohn's Disease Patients Undergoing Multidetector CT-Enterography 153
Beyond Irritable Bowel Syndrome: The Efficacy of the Low Fodmap Diet for Improving Symptoms in Inflammatory Bowel Diseases and Celiac Disease 153
Diagnostic Accuracy of Ultrasonography in the Detection of Postsurgical Recurrence in Crohn's Disease: A Systematic Review with Meta-analysis 152
Different profile of efficacy of thiopurines in ulcerative colitis and Crohn's disease 152
Psoriasis Features in Patients with Inflammatory Bowel Disease 152
Gut microbiota and Crohn's disease 149
Efficacy of a "contact center-based communication" in optimizing the care of inflammatory bowel diseases 143
The burden of anaemia in patients with inflammatory bowel diseases 142
The metabolic role of gut microbiota in the development of nonalcoholic fatty liver disease and cardiovascular disease 141
The impact of a dedicated contact centre on the clinical outcome of patients with inflammatory bowel disease during the COVID-19 outbreak 137
Exclusive Enteral Nutrition in Adult Crohn’s Disease: an Overview of Clinical Practice and Perceived Barriers 136
Gut Microbes and Hepatic Encephalopathy: From the Old Concepts to New Perspectives 134
Probiotics in Gastrointestinal Diseases: All that Glitters Is Not Gold 133
One-year clinical outcomes with biologics in Crohn's disease: transmural healing compared with mucosal or no healing. 132
Effectiveness of Partial Enteral Nutrition as Add-On to Biologics in Patients With Refractory and Difficult-to-Treat Crohn’s Disease: A Pilot Study 131
Combined endoscopic/sonographic-based risk matrix model for predicting one-year risk of surgery: A prospective observational study of a tertiary centre severe/refractory crohn's disease cohort 131
Time to grow up: readiness associated with improved clinical outcomes in pediatric inflammatory bowel disease patients undergoing transition 130
Exploring the concept of deep remission in Crohn's disease: correlation between transmural healing and biomarkers 128
Sexual dysfunctions in inflammatory bowel disease: role of Mediterranean diet and quality of life 128
Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study 125
Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile Infection 124
Gut microbiota and irritable bowel syndrome 122
Italian validation of the IBD-disk tool for the assessment of disability in inflammatory bowel diseases: A cross-sectional multicenter study 118
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study 114
Inflammatory Bowel Diseases and Sarcopenia: The Role of Inflammation and Gut Microbiota in the Development of Muscle Failure 114
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study 111
An International Multicenter Real-Life Prospective Study of Electronic Chromoendoscopy Score PICaSSO in Ulcerative Colitis 107
Noninvasive monitoring of inflammatory bowel disease in the post COVID-19 era 105
Can a transition clinic bridge the gap between paediatric and adult inflammatory bowel disease care models? 104
David Against Goliath: Direct Comparison of Handheld Bowel Sonography and Magnetic Resonance Enterography for Diagnosis of Crohn's Disease 101
Rates of Endoscopic Recurrence In Postoperative Crohn's Disease Based on Anastomotic Techniques: A Systematic Review And Meta-Analysis 100
Insights into disability and psycho-social care of patients with inflammatory bowel disease 98
Treatment-based risk stratification of infections in inflammatory bowel disease: A comparison between anti-tumor necrosis factor-α and nonbiological exposure in real-world setting. 97
The Impact of Intestinal Ultrasound on the Management of Inflammatory Bowel Disease: From Established Facts Toward New Horizons 96
Objective comparison of vedolizumab and ustekinumab effectiveness in Crohn's disease patients failure to TNF-alpha inhibitors 94
Computer-Aided Imaging Analysis of Probe-Based Confocal Laser Endomicroscopy With Molecular Labeling and Gene Expression Identifies Markers of Response to Biological Therapy in IBD Patients: The Endo-Omics Study 91
Lactose intolerance assessed by analysis of genetic polymorphism, breath test and symptoms in patients with inflammatory bowel disease 90
Efficacy and safety of Advanced Combination Treatment in immune-mediated inflammatory disease: A systematic review and meta-analysis of randomized controlled trials 84
Inflammation-Driven Colorectal Cancer Associated with Colitis: From Pathogenesis to Changing Therapy 77
PICaSSO virtual electronic chromendoscopy accurately reflects combined endoscopic and histological assessment for prediction of clinical outcomes in ulcerative colitis 74
Validation of a new optical diagnosis training module to improve dysplasia characterization in inflammatory bowel disease: a multicenter international study 73
Transition care in patients with IBD: The pediatric and the adult gastroenterologist's perspective. Results from a national survey 72
Insights into Probiotic Prescription among Gastroenterologists and Other Healthcare Professionals: Evidence from an Italian Survey 72
New endoscopic tools in inflammatory bowel disease 70
Advanced technology for assessment of endoscopic and histological activity in ulcerative colitis: a systematic review and meta-analysis 70
Advancing perioperative optimization in Crohn's disease surgery with machine learning predictions 69
Venous and arterial thromboembolism in out-patients with inflammatory bowel disease: a single center study. 64
Neutrophil-only histological assessment of ulcerative colitis correlates with endoscopic activity and predicts long-term outcomes in a multicenter study 64
Can advanced endoscopic techniques for assessment of mucosal inflammation and healing approximate histology in inflammatory bowel disease? 63
Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis 63
Reproducibility of the electronic chromoendoscopy PICaSSO score (Paddington International Virtual ChromoendoScopy ScOre) in ulcerative colitis using multiple endoscopic platforms: a prospective multicenter international study (with video) 63
Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab 62
Image-Enhanced Endoscopy Surveillance of Colon and Pouch Dysplasia in IBD 62
Small molecule oral targeted therapies in ulcerative colitis 59
A virtual chromoendoscopy artificial intelligence system to detect endoscopic and histologic activity/remission and predict clinical outcomes in ulcerative colitis 58
Key challenges and care approaches in inflammatory pouch disorders: What can we do better? 58
Endoscopy and histology in inflammatory bowel diseases patients: Complementary or alternatives?-Author's reply 58
Image-Enhanced Endoscopy in the Surveillance of Colitis-Associated Neoplasia 57
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey 56
Endocytoscopy with automated multispectral intestinal barrier pathology imaging for assessment of deep healing to predict outcomes in ulcerative colitis 56
MMX mesalamine: A modern twist on a classic treatment 53
Addressing unmet needs of gastroenterologists' training in the post-COVID-19 era 53
Heterogeneity of definition of upper gastrointestinal tract in different guidelines of Crohn's disease: A scoping review 53
Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD) 53
Insights into Mesalazine Use in Clinical Practice of Young Gastroenterologists 52
Real-world use of endoscopic and histological indices in ulcerative colitis: Results of a global survey 51
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 50
Performance measures for colonoscopy in inflammatory bowel disease patients: European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative 49
Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year 49
Fecal Calprotectin Thresholds to Predict Endoscopic Remission Using Advanced Optical Enhancement Techniques and Histological Remission in IBD Patients 48
Clinical outcomes, predictors of prognosis and health economics consequences in IBD patients after discontinuation of the first biological therapy 46
Raman spectroscopy accurately differentiates mucosal healing from non-healing and biochemical changes following biological therapy in inflammatory bowel disease 46
Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis-An Exploratory Study to Define Deep Remission 45
AI and endoscopy/histology in UC: the rise of machine 45
Predicting Outcome after Acute Severe Ulcerative Colitis: A Contemporary Review and Areas for Future Research 44
Sarcopenia: A new route on the map for risk stratification in inflammatory bowel disease 41
Reducing diagnostic delays of extraintestinal manifestations in inflammatory bowel disease: a comparative study of a multidisciplinary outpatient clinic versus conventional referral specialists 41
Digital biomarkers and artificial intelligence: a new frontier in personalized management of inflammatory bowel disease 31
Risk of avoidant/restrictive food intake disorders in patients with inflammatory bowel disease: a matched cross-sectional case-control study 19
Bowel Urgency Improvement Correlates With Clinical, Biochemical, and Intestinal Ultrasound Improvements in Inflammatory Bowel Disease: A Cross Sectional Multicenter Study 19
Comparative analysis of sporadic, IBD-associated, early-onset and late-onset colorectal cancer: a systematic review and meta-analysis 16
Unveiling the effectiveness of Chat-GPT 4.0, an artificial intelligence conversational tool, for addressing common patient queries in gastrointestinal endoscopy 15
Artificial Intelligence in Advancing Inflammatory Bowel Disease Management: Setting New Standards 15
Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class 15
Inflammatory Bowel Diseases and Nephropathies: Exploring the Gut–Kidney Axis 15
Global perspectives on sustainable IBD care 14
The role of fecal calprotectin in assessing response to advanced medical treatments for inflammatory bowel diseases: a review of the literature 14
Impact of COVID-19 outbreak on clinical practice and training of young gastroenterologists: A European survey 14
Soluble Blood Markers of Mucosal Healing in Inflammatory Bowel Disease: The Future of Noninvasive Monitoring 13
Adiponectin and phase angle in the assessment of sarcopenia in Crohn’s disease: beyond muscle mass 13
Prevalence of disability in inflammatory bowel disease: a systematic review and meta-analysis 13
Attaining sustainability in inflammatory bowel disease 13
Totale 8.423
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.856
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.856
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022183 0 0 2 2 1 2 0 9 12 12 52 91
2022/2023333 30 44 6 29 43 38 3 30 42 46 15 7
2023/2024335 7 35 15 15 10 28 62 45 6 5 69 38
2024/20252.152 108 101 6 16 65 108 266 124 125 242 778 213
2025/20265.037 459 534 565 460 661 175 496 263 673 321 198 232
2026/2027238 179 59 0 0 0 0 0 0 0 0 0 0
Totale 8.546